Evolent Health (EVH) Competitors $12.38 -0.29 (-2.29%) (As of 11/15/2024 ET) Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends EVH vs. QXO, ETSY, TNET, NVEI, DXC, ALIT, PAYO, CARG, LIF, and STNEShould you be buying Evolent Health stock or one of its competitors? The main competitors of Evolent Health include QXO (QXO), Etsy (ETSY), TriNet Group (TNET), Nuvei (NVEI), DXC Technology (DXC), Alight (ALIT), Payoneer Global (PAYO), CarGurus (CARG), Life360 (LIF), and StoneCo (STNE). These companies are all part of the "business services" industry. Evolent Health vs. QXO Etsy TriNet Group Nuvei DXC Technology Alight Payoneer Global CarGurus Life360 StoneCo Evolent Health (NYSE:EVH) and QXO (NASDAQ:QXO) are both computer and technology companies, but which is the better investment? We will compare the two companies based on the strength of their dividends, institutional ownership, community ranking, valuation, risk, analyst recommendations, media sentiment, earnings and profitability. Does the media favor EVH or QXO? In the previous week, Evolent Health had 9 more articles in the media than QXO. MarketBeat recorded 16 mentions for Evolent Health and 7 mentions for QXO. QXO's average media sentiment score of 0.31 beat Evolent Health's score of -0.14 indicating that QXO is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Evolent Health 1 Very Positive mention(s) 2 Positive mention(s) 6 Neutral mention(s) 3 Negative mention(s) 0 Very Negative mention(s) Neutral QXO 0 Very Positive mention(s) 0 Positive mention(s) 5 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Neutral Do insiders and institutionals hold more shares of EVH or QXO? 58.7% of QXO shares are owned by institutional investors. 1.6% of Evolent Health shares are owned by insiders. Comparatively, 51.3% of QXO shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term. Is EVH or QXO more profitable? QXO has a net margin of 30.08% compared to Evolent Health's net margin of -2.93%. QXO's return on equity of 12.22% beat Evolent Health's return on equity.Company Net Margins Return on Equity Return on Assets Evolent Health-2.93% 6.30% 2.57% QXO 30.08%12.22%5.79% Which has more volatility & risk, EVH or QXO? Evolent Health has a beta of 1.58, meaning that its share price is 58% more volatile than the S&P 500. Comparatively, QXO has a beta of 2.32, meaning that its share price is 132% more volatile than the S&P 500. Do analysts prefer EVH or QXO? Evolent Health currently has a consensus target price of $29.50, suggesting a potential upside of 138.29%. Given Evolent Health's stronger consensus rating and higher probable upside, research analysts clearly believe Evolent Health is more favorable than QXO.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Evolent Health 0 Sell rating(s) 1 Hold rating(s) 9 Buy rating(s) 1 Strong Buy rating(s) 3.00QXO 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Does the MarketBeat Community believe in EVH or QXO? Evolent Health received 557 more outperform votes than QXO when rated by MarketBeat users. CompanyUnderperformOutperformEvolent HealthOutperform Votes55774.27% Underperform Votes19325.73% QXON/AN/A Which has preferable earnings and valuation, EVH or QXO? QXO has lower revenue, but higher earnings than Evolent Health. Evolent Health is trading at a lower price-to-earnings ratio than QXO, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioEvolent Health$2.46B0.58-$113.04M-$0.91-13.60QXO$57.11M110.41-$1.07M-$9.12-1.69 SummaryQXO beats Evolent Health on 10 of the 18 factors compared between the two stocks. Ad Weiss RatingsThe centerpiece of Trump’s crypto’s masterplan …Donald Trump wants to be America’s first crypto president. He was the keynote speaker at the recent Bitcoin conference in Nashville … Where he told an adoring crowd that the U.S. would become … “The crypto capital of the planet and the Bitcoin superpower of the world.”Click here to find out more about what could be Trump and JD Vance’s favorite coin. Get Evolent Health News Delivered to You Automatically Sign up to receive the latest news and ratings for EVH and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart EVH vs. The Competition Export to ExcelMetricEvolent HealthManagement services IndustryComputer SectorNYSE ExchangeMarket Cap$1.44B$7.05B$24.54B$19.81BDividend YieldN/A3.23%2.79%3.50%P/E Ratio-13.6012.62246.1342.29Price / Sales0.582.173,388.7920.78Price / Cash7.1416.2035.6621.65Price / Book1.398.546.864.66Net Income-$113.04M$136.00M$677.40M$983.45M7 Day Performance-7.34%-3.93%-2.22%-2.12%1 Month Performance-50.40%-7.78%-0.03%-0.39%1 Year Performance-57.79%-3.08%16.81%23.34% Evolent Health Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)EVHEvolent Health3.4492 of 5 stars$12.38-2.3%$29.50+138.3%-58.0%$1.44B$2.46B-13.604,700Analyst ForecastShort Interest ↑QXOQXO1.0196 of 5 stars$16.14+0.6%N/AN/A$6.61B$57.11M-1.31195News CoverageHigh Trading VolumeETSYEtsy4.6933 of 5 stars$54.00+1.3%N/A-29.3%$6.07B$2.75B27.552,420TNETTriNet Group4.3458 of 5 stars$96.29+3.8%N/A-16.5%$4.77B$4.92B18.553,600Positive NewsNVEINuvei1.5465 of 5 stars$33.57+0.1%N/A+73.3%$4.76B$1.31B-372.962,202Dividend AnnouncementShort Interest ↑News CoverageDXCDXC Technology2.6329 of 5 stars$22.77+5.1%N/A-7.4%$4.12B$13.67B284.66130,000Short Interest ↓ALITAlight4.0386 of 5 stars$7.46+1.6%N/A+6.0%$4.08B$3.36B-16.9518,000Earnings ReportDividend AnnouncementAnalyst ForecastInsider SellingNews CoveragePAYOPayoneer Global4.0308 of 5 stars$10.39-3.9%N/A+88.5%$3.97B$940.30M29.692,167Insider SellingCARGCarGurus3.612 of 5 stars$36.51+4.9%N/A+77.3%$3.77B$914.24M-79.371,343LIFLife3600.9486 of 5 stars$48.19+1.5%N/AN/A$3.57B$304.52M0.00600Analyst ForecastInsider SellingShort Interest ↑News CoverageGap DownSTNEStoneCo4.9973 of 5 stars$11.56+2.3%N/A-28.7%$3.57B$2.41B9.4017,091Analyst ForecastNews Coverage Related Companies and Tools Related Companies QXO Alternatives ETSY Alternatives TNET Alternatives NVEI Alternatives DXC Alternatives ALIT Alternatives PAYO Alternatives CARG Alternatives LIF Alternatives STNE Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NYSE:EVH) was last updated on 11/17/2024 by MarketBeat.com Staff From Our PartnersBill Gates’s Next Big AI Bet: StargateIn February 2016… when almost nobody was talking about artificial intelligence…. I picked Nvidia as one of ...Brownstone Research | SponsoredThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredThere is a little known company that is changing warfareWith geo - political instability around the world investors are flocking to defense contract stocks. There...Reticulate | SponsoredNvidia’s world of pain awaitsThe Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredTrump Wins… But Elon Says Get Ready to BraceTrump's back in the White House, ready to hit the gas on America's comeback. He's taking on the economy wi...Genesis Gold Group | SponsoredUnveiled: NVIDIA’s "Secret Royalty" ProgramDid you know that there's an investment that will give you the opportunity to collect "royalties" every time N...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Evolent Health, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Evolent Health With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
